The 5th M2M Track will take place during the 31st Annual Congress of the European Association of Nuclear Medicine in Düsseldorf, Germany, October 13–17, 2018.
Since 2014, the M2M sessions have constituted a successful track in the programme of the annual EANM Congress. By addressing a wide range of scientific aspects, these sessions have succeeded in attracting scientists, industry representatives and clinicians. A successful stepping stone for translational science has thereby been established. The M2M track actively stimulates multidisciplinary interplay between the various scientific disciplines concerned with molecular imaging and therapy, namely chemistry, engineering, physics, biology and medicine.
The M2M track comprises a series of plenary lectures, CME sessions, symposia and focused scientific sessions, all of which have the aim of connecting fundamental research with unmet medical needs and vice versa.
The EANM Committees for Translational Molecular Imaging and Therapy, Drug Development, and Radiopharmacy jointly coordinate the scientific programme of the M2M track, while the EANM Executive Office handles organisational matters.
We look forward to receiving your stimulating scientific abstracts and hope to welcome you at the M2M Track in Düsseldorf in October 2018!